BACK TO MAIN TOXICITY TO AQUATIC PLANTS (SELENASTRUM CAPRICORNUTUM) TEST SUBSTANCE Identity: Perfluorooctanoic acid, tetrabutylammonium salt; may also be referred to as PFOA tetrabutylammonium salt, tetrabutylammonium perfluorooctanoate, N2803-2, or as a major component of L -13492.

Z-*7 RtV. fl-*2 ffPOBI) C3TABL($>*KO 1*02 E.

AR226-3037 Study Title Eye Irritation Test with H-21460 in Rabbits Laboratory Project ID Haskell Laboratory Report No. 82-96 Author Tracy A.

CONFIDENTIAL AR226-3127 DPT 432/985069/SS SKIN SENSmZATION TO THE GUINEA-PIG (MAGNUSSON & KLIGMAN METHOD) Sponsor DuPont Specialty Chemicals Jackson Laboratory.

AR226-3143 TRADE SECRET Study Title H-24256: Oral Approximate Lethal Dose (ALD) in Rats Laboratory Project ID: DuPont-3628 AUTHOR: Carol Finlay, B.A.

Summary PFOS Rat Cross-Fostering StudyNumbers:3M T-6295.13,Argus418-014 Compound & Lot: PFOS (Perfluorooctanesulfona-teL)ot 217,98.4% pure(SMD AnalyticalRequest 53030) C.A.S.

coming HazletonInc.

ACUTE TOXICITY TO FISH (FATHEAD MINNOW) TEST SUBSTANCE Identity:Mixturecontainingperfluorooctanesulfonawtheich may also be referredto as PFOS, FC-95, or as a component of FC-201 F. (1-Octanesulfonicacid,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-p,otassium salt,CAS # 2795-39-3) Remarks: The 3M productionlotnumber was 1.

ACUTE TOXICITY TO FISH (FATHEAD MINNOW) TEST ellm'zTAK'rl= ldenfity:Mixturecontainingperfluorooctanesulfonawtheich may alsobe referredto as PFOS, FC-95, oras a component ofFC-3003. (1Octanesulfonicacid)(CAS # 2795-39-3).

ADVANCED BIOANALYTICAL SERVICES, INC.

ARu .6-0337 ACUTE TOXICITY TO FISH TEST SUBSTANCE Identity: N-Ethylperfluorooctanesulfonamide; may also be referred to as U1464, EtFOSA, EtPOSA, F-6309, or FX-12. (1Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-N-ethyl-, CAS # 4151-50-2) Remarks: Material is a white solid.

BACK TO MAIN Study Title Acuta Toxicity oi!

ARNG-054?

.

C 355/2 EN Official Journal of the European Communities 20.11.98 Communication from the Commission to the Council and the European Parliament: Strategy for the phaseout of CFCs in metered-dose inhalers (98/C 355/02) COM(1998) 603 final CHAPTER 1 INTRODUCTION 1.1.Decision IX/19 of the Parties to the Montreal Protocol requires Parties requesting essential use nominations for chlorofluorocarbons CFCs for metered-dose inhalers (MDI) to present to the Ozone Secretariat an initial national or regional transition strategy if possible by 31 January 1998, and in any case by 31 January 1999.